CHRISTINA WEISS: Open Payments
NPI 1497130736 · PARAMUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$155 in 8 payments from 4 companies in 2025. Trend: 2023 $1,779 · 2024 $801 · 2025 $155
Food & beverage: $155
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 5 | $108 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Almatica Pharma LLC | 1 | $16 |
| ABBVIE INC. | 1 | $14 |
Products named: INGREZZA, COBENFY, LOREEV XR, QULIPTA.
Industry payments across NJ — which companies pay providers there.
